News & Analysis on Clinical Trial Services & Contract Research And Development
Avanir Pharmaceuticals has bought North American rights to OptiNose’s novel intranasal delivery system to treat acute migraines, which is expected to be filed for US FDA approval by early 2014.
Teva says it will reap the benefits of changing attitudes to generic drugs in Japan as it doubles its production capacity in the country.
A consortium of European vaccine experts, including the Swiss CRO Preclin Biosystems, has received almost €5.5m ($7.1m) from the EU to develop a vaccine against the deadly MRSA bacteria.
Increased challenges in drug delivery have led to Catalent integrating its technologies and services in order to create a new business unit.
Programming errors in a vendor's EDC system meant some patients were mistakenly given placebo during a trial of an ALS (amyotrophic lateral sclerosis) drug candidate being developed by Cytokinetics.
Saltigo has won a manufacturing contract with Daiichi Sankyo under it which it will provide custom synthesis services for one of the Japanese drugmaker’s pipeline candidates.
Fresenius Kabi has received a warning letter from the FDA regarding its API facility in India.